| 0 |
BIOPSY CORNEA |
1 |
0.3333 |
| 1 |
AMOEBIC BRAIN ABSCESS |
2 |
0.2500 |
| 2 |
BALAMUTHIA INFECTION |
6 |
0.2069 |
| 3 |
ACANTHAMOEBA KERATITIS |
7 |
0.1892 |
| 4 |
CILIARY BODY DEGENERATION |
1 |
0.1111 |
| 5 |
ACANTHAMOEBA INFECTION |
15 |
0.0798 |
| 6 |
GOOD SYNDROME |
1 |
0.0556 |
| 7 |
ENCEPHALITIS PROTOZOAL |
3 |
0.0536 |
| 8 |
MENINGOENCEPHALITIS AMOEBIC |
3 |
0.0517 |
| 9 |
MUCOCUTANEOUS LEISHMANIASIS |
6 |
0.0492 |
| 10 |
RICKETTSIOSIS |
1 |
0.0455 |
| 11 |
KWASHIORKOR |
1 |
0.0417 |
| 12 |
AMNIOTIC MEMBRANE GRAFT |
1 |
0.0385 |
| 13 |
ACUTE HAEMORRHAGIC LEUKOENCEPHALITIS |
1 |
0.0278 |
| 14 |
VISCERAL LEISHMANIASIS |
20 |
0.0277 |
| 15 |
KERATOUVEITIS |
1 |
0.0270 |
| 16 |
ALEXIA |
2 |
0.0247 |
| 17 |
KERATOPLASTY |
1 |
0.0238 |
| 18 |
LEISHMANIASIS |
5 |
0.0172 |
| 19 |
ABDOMINAL WALL OEDEMA |
1 |
0.0159 |
| 20 |
QUADRANTANOPIA |
2 |
0.0153 |
| 21 |
BACTERIA SPUTUM IDENTIFIED |
1 |
0.0132 |
| 22 |
ANAL RASH |
1 |
0.0104 |
| 23 |
CARDIAC VALVE VEGETATION |
5 |
0.0103 |
| 24 |
SCEDOSPORIUM INFECTION |
7 |
0.0099 |
| 25 |
CORNEAL TOXICITY |
1 |
0.0090 |
| 26 |
CENTRAL NERVOUS SYSTEM FUNGAL INFECTION |
2 |
0.0086 |
| 27 |
ATROPHY OF GLOBE |
1 |
0.0078 |
| 28 |
CYTOKINE INCREASED |
1 |
0.0074 |
| 29 |
BLASTOMYCOSIS |
3 |
0.0062 |
| 30 |
PRODUCT INEFFECTIVE |
4 |
0.0051 |
| 31 |
CORNEAL GRAFT REJECTION |
1 |
0.0048 |
| 32 |
POST PROCEDURAL OEDEMA |
1 |
0.0043 |
| 33 |
CRANIOFACIAL DEFORMITY |
1 |
0.0043 |
| 34 |
AMOEBIASIS |
1 |
0.0043 |
| 35 |
CORNEAL NEOVASCULARISATION |
1 |
0.0040 |
| 36 |
CORNEAL THINNING |
1 |
0.0039 |
| 37 |
CENTRAL NERVOUS SYSTEM NECROSIS |
1 |
0.0036 |
| 38 |
OCULAR SURFACE DISEASE |
1 |
0.0036 |
| 39 |
SUBCUTANEOUS NODULE |
1 |
0.0035 |
| 40 |
KERATITIS |
10 |
0.0033 |
| 41 |
INFECTIOUS PLEURAL EFFUSION |
5 |
0.0033 |
| 42 |
NEPHRITIC SYNDROME |
1 |
0.0032 |
| 43 |
CORNEAL INFILTRATES |
1 |
0.0032 |
| 44 |
DRUG LEVEL CHANGED |
2 |
0.0032 |
| 45 |
CORNEAL PERFORATION |
2 |
0.0032 |
| 46 |
VASOGENIC CEREBRAL OEDEMA |
2 |
0.0028 |
| 47 |
HERPES SIMPLEX REACTIVATION |
1 |
0.0026 |
| 48 |
LYMPHANGITIS |
2 |
0.0025 |
| 49 |
HYPOPYON |
2 |
0.0024 |
| 50 |
HYPOTONY OF EYE |
1 |
0.0024 |
| 51 |
GASTROINTESTINAL STOMA OUTPUT INCREASED |
1 |
0.0021 |
| 52 |
KAPOSI'S SARCOMA |
1 |
0.0020 |
| 53 |
BRAIN ABSCESS |
5 |
0.0020 |
| 54 |
VISCERAL CONGESTION |
1 |
0.0020 |
| 55 |
HUMAN POLYOMAVIRUS INFECTION |
1 |
0.0019 |
| 56 |
PRODUCT INEFFECTIVE FOR UNAPPROVED USE |
5 |
0.0019 |
| 57 |
CHIKUNGUNYA VIRUS INFECTION |
1 |
0.0018 |
| 58 |
LUNG CONSOLIDATION |
5 |
0.0018 |
| 59 |
PLEOCYTOSIS |
1 |
0.0017 |
| 60 |
NEURODEGENERATIVE DISORDER |
1 |
0.0016 |
| 61 |
REFLEXES ABNORMAL |
1 |
0.0015 |
| 62 |
ULCERATIVE KERATITIS |
4 |
0.0015 |
| 63 |
BLOOD BILIRUBIN UNCONJUGATED INCREASED |
1 |
0.0014 |
| 64 |
FINGER AMPUTATION |
1 |
0.0014 |
| 65 |
LOCAL REACTION |
1 |
0.0013 |
| 66 |
ENCEPHALITIS |
9 |
0.0013 |
| 67 |
CORNEAL TRANSPLANT |
1 |
0.0013 |
| 68 |
CSF PROTEIN INCREASED |
1 |
0.0012 |
| 69 |
JC VIRUS TEST POSITIVE |
1 |
0.0012 |
| 70 |
ATONIC SEIZURES |
1 |
0.0012 |
| 71 |
SQUAMOUS CELL CARCINOMA OF SKIN |
7 |
0.0012 |
| 72 |
PUNCTATE KERATITIS |
1 |
0.0011 |
| 73 |
OTOTOXICITY |
2 |
0.0011 |
| 74 |
URINARY TRACT INFECTION ENTEROCOCCAL |
1 |
0.0011 |
| 75 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
57 |
0.0010 |
| 76 |
HAEMOPHILUS INFECTION |
1 |
0.0010 |
| 77 |
CD4 LYMPHOCYTES DECREASED |
2 |
0.0009 |
| 78 |
CORNEAL DISORDER |
2 |
0.0009 |
| 79 |
NOSOCOMIAL INFECTION |
2 |
0.0009 |
| 80 |
OCULAR TOXICITY |
1 |
0.0009 |
| 81 |
DRUG LEVEL BELOW THERAPEUTIC |
5 |
0.0009 |
| 82 |
STREPTOCOCCAL SEPSIS |
1 |
0.0008 |
| 83 |
BETA HAEMOLYTIC STREPTOCOCCAL INFECTION |
1 |
0.0008 |
| 84 |
ELECTROLYTE IMBALANCE |
9 |
0.0008 |
| 85 |
CORNEAL OPACITY |
1 |
0.0007 |
| 86 |
NECROSIS |
4 |
0.0007 |
| 87 |
POST HERPETIC NEURALGIA |
1 |
0.0007 |
| 88 |
SUPERINFECTION |
1 |
0.0007 |
| 89 |
PALLIATIVE CARE |
1 |
0.0007 |
| 90 |
DRUG LEVEL DECREASED |
6 |
0.0006 |
| 91 |
MYCOBACTERIAL INFECTION |
1 |
0.0006 |
| 92 |
PSEUDOMONAL SEPSIS |
1 |
0.0006 |
| 93 |
FOOD INTERACTION |
1 |
0.0006 |
| 94 |
TRANSPLANT DYSFUNCTION |
1 |
0.0006 |
| 95 |
BLOOD HIV RNA INCREASED |
1 |
0.0006 |
| 96 |
PATHOGEN RESISTANCE |
5 |
0.0005 |
| 97 |
MACULAR OEDEMA |
3 |
0.0005 |
| 98 |
SACROILIITIS |
1 |
0.0005 |
| 99 |
MULTI-ORGAN DISORDER |
1 |
0.0005 |
| 100 |
DISEASE RECURRENCE |
24 |
0.0005 |
| 101 |
PHOTOSENSITIVITY REACTION |
8 |
0.0005 |
| 102 |
STAPHYLOCOCCUS TEST POSITIVE |
1 |
0.0005 |
| 103 |
LIPODYSTROPHY ACQUIRED |
1 |
0.0005 |
| 104 |
HYPERTRANSAMINASAEMIA |
3 |
0.0004 |
| 105 |
PANNICULITIS |
1 |
0.0004 |
| 106 |
SELF ESTEEM DECREASED |
1 |
0.0004 |
| 107 |
DRUG RESISTANCE |
10 |
0.0004 |
| 108 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
11 |
0.0004 |
| 109 |
MYCOBACTERIUM AVIUM COMPLEX INFECTION |
1 |
0.0004 |
| 110 |
UVEITIS |
5 |
0.0004 |
| 111 |
RASH MORBILLIFORM |
1 |
0.0004 |
| 112 |
HAEMOTHORAX |
1 |
0.0003 |
| 113 |
GASTROINTESTINAL NECROSIS |
1 |
0.0003 |
| 114 |
CHEST X-RAY ABNORMAL |
1 |
0.0003 |
| 115 |
LIVER INJURY |
8 |
0.0003 |
| 116 |
BRAIN DEATH |
1 |
0.0003 |
| 117 |
FAMILY STRESS |
1 |
0.0003 |
| 118 |
BRAIN OEDEMA |
4 |
0.0003 |
| 119 |
IRIDOCYCLITIS |
1 |
0.0003 |
| 120 |
TRANSAMINASES INCREASED |
7 |
0.0003 |
| 121 |
ASPERGILLUS INFECTION |
2 |
0.0003 |
| 122 |
DEAFNESS NEUROSENSORY |
1 |
0.0003 |
| 123 |
IMMUNOSUPPRESSANT DRUG LEVEL INCREASED |
1 |
0.0003 |
| 124 |
BK VIRUS INFECTION |
1 |
0.0003 |
| 125 |
GRANULOMA |
1 |
0.0003 |
| 126 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
8 |
0.0003 |
| 127 |
AMYLASE INCREASED |
1 |
0.0003 |
| 128 |
HEPATOTOXICITY |
6 |
0.0003 |
| 129 |
BRONCHOPULMONARY ASPERGILLOSIS |
2 |
0.0003 |
| 130 |
HEMIPLEGIA |
2 |
0.0002 |
| 131 |
CARDIAC FAILURE CHRONIC |
1 |
0.0002 |
| 132 |
PANCYTOPENIA |
13 |
0.0002 |
| 133 |
STAPHYLOCOCCAL BACTERAEMIA |
1 |
0.0002 |
| 134 |
BLOOD CREATINE INCREASED |
1 |
0.0002 |
| 135 |
CYTOMEGALOVIRUS VIRAEMIA |
1 |
0.0002 |
| 136 |
GOUT |
4 |
0.0002 |
| 137 |
VASCULAR DEVICE INFECTION |
1 |
0.0002 |
| 138 |
ACUTE GRAFT VERSUS HOST DISEASE |
1 |
0.0002 |
| 139 |
DRUG LEVEL ABOVE THERAPEUTIC |
1 |
0.0002 |
| 140 |
ISCHAEMIA |
1 |
0.0002 |
| 141 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 142 |
GASTROINTESTINAL TOXICITY |
1 |
0.0002 |
| 143 |
ENTEROCOCCAL INFECTION |
1 |
0.0002 |
| 144 |
ABASIA |
5 |
0.0002 |
| 145 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 146 |
KLEBSIELLA INFECTION |
1 |
0.0002 |
| 147 |
POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER |
1 |
0.0002 |
| 148 |
DRUG-INDUCED LIVER INJURY |
6 |
0.0002 |
| 149 |
PRODUCT PRESCRIBING ISSUE |
4 |
0.0002 |
| 150 |
EYE DISORDER |
6 |
0.0002 |
| 151 |
NEPHROPATHY TOXIC |
2 |
0.0002 |
| 152 |
THERAPY CESSATION |
9 |
0.0002 |
| 153 |
HYPERKALAEMIA |
6 |
0.0002 |
| 154 |
GASTROINTESTINAL DISORDER |
15 |
0.0002 |
| 155 |
ENDOPHTHALMITIS |
1 |
0.0002 |
| 156 |
RENAL FAILURE ACUTE |
7 |
0.0002 |
| 157 |
GLOMERULAR FILTRATION RATE DECREASED |
2 |
0.0002 |
| 158 |
OLIGURIA |
1 |
0.0002 |
| 159 |
THERAPY NON-RESPONDER |
7 |
0.0002 |
| 160 |
HAEMOGLOBIN ABNORMAL |
1 |
0.0002 |
| 161 |
BLOOD BILIRUBIN INCREASED |
4 |
0.0001 |
| 162 |
BONE MARROW FAILURE |
3 |
0.0001 |
| 163 |
TREATMENT NONCOMPLIANCE |
8 |
0.0001 |
| 164 |
NEPHROTIC SYNDROME |
1 |
0.0001 |
| 165 |
CENTRAL NERVOUS SYSTEM LESION |
2 |
0.0001 |
| 166 |
OFF LABEL USE |
122 |
0.0001 |
| 167 |
DERMATITIS BULLOUS |
1 |
0.0001 |
| 168 |
RASH PUSTULAR |
1 |
0.0001 |
| 169 |
RENAL FAILURE |
18 |
0.0001 |
| 170 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
1 |
0.0001 |
| 171 |
TREATMENT FAILURE |
11 |
0.0001 |
| 172 |
LIPASE INCREASED |
1 |
0.0001 |
| 173 |
DRUG INTOLERANCE |
12 |
0.0001 |
| 174 |
SHOCK HAEMORRHAGIC |
1 |
0.0001 |
| 175 |
POLYURIA |
1 |
0.0001 |
| 176 |
RENAL IMPAIRMENT |
10 |
0.0001 |
| 177 |
PYELONEPHRITIS |
1 |
0.0001 |
| 178 |
DEAFNESS |
3 |
0.0001 |
| 179 |
INTENTIONAL PRODUCT MISUSE |
10 |
0.0001 |
| 180 |
PURPURA |
1 |
0.0001 |
| 181 |
CARDIOTOXICITY |
1 |
0.0001 |
| 182 |
ACUTE KIDNEY INJURY |
17 |
0.0001 |
| 183 |
CONDITION AGGRAVATED |
33 |
0.0001 |
| 184 |
HYPOKALAEMIA |
5 |
0.0001 |
| 185 |
DEFORMITY |
1 |
0.0001 |
| 186 |
TUBULOINTERSTITIAL NEPHRITIS |
2 |
0.0001 |
| 187 |
SQUAMOUS CELL CARCINOMA |
1 |
0.0001 |
| 188 |
HAEMATOTOXICITY |
1 |
0.0001 |
| 189 |
PRODUCT USE IN UNAPPROVED INDICATION |
26 |
0.0001 |
| 190 |
LIVER FUNCTION TEST ABNORMAL |
3 |
0.0001 |
| 191 |
PHARYNGEAL SWELLING |
1 |
0.0001 |
| 192 |
THERAPY CHANGE |
1 |
0.0001 |
| 193 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
7 |
0.0001 |
| 194 |
BLINDNESS |
4 |
0.0001 |
| 195 |
TOXICITY TO VARIOUS AGENTS |
16 |
0.0001 |
| 196 |
DECREASED APPETITE |
22 |
0.0001 |
| 197 |
HALLUCINATION |
7 |
0.0001 |
| 198 |
BLOOD CREATININE INCREASED |
6 |
0.0001 |
| 199 |
POST PROCEDURAL HAEMORRHAGE |
1 |
0.0001 |
| 200 |
MYOCLONUS |
1 |
0.0001 |
| 201 |
DRUG INEFFECTIVE |
109 |
0.0001 |
| 202 |
RESPIRATORY FAILURE |
6 |
0.0001 |
| 203 |
NEUTROPENIA |
11 |
0.0001 |
| 204 |
ADVERSE DRUG REACTION |
7 |
0.0001 |
| 205 |
NAUSEA |
59 |
0.0001 |
| 206 |
NEUTROPHIL COUNT DECREASED |
3 |
0.0001 |
| 207 |
HEPATIC ENZYME INCREASED |
5 |
0.0001 |
| 208 |
SKIN LESION |
2 |
0.0001 |
| 209 |
VISUAL IMPAIRMENT |
9 |
0.0001 |
| 210 |
RESPIRATORY DISTRESS |
2 |
0.0001 |
| 211 |
SKIN REACTION |
1 |
0.0001 |
| 212 |
VOMITING |
33 |
0.0001 |
| 213 |
BALANCE DISORDER |
6 |
0.0001 |
| 214 |
SEPTIC SHOCK |
3 |
0.0001 |
| 215 |
DISEASE PROGRESSION |
8 |
0.0001 |
| 216 |
DYSGEUSIA |
5 |
0.0001 |
| 217 |
APHASIA |
2 |
0.0001 |
| 218 |
ALANINE AMINOTRANSFERASE INCREASED |
4 |
0.0001 |
| 219 |
LYMPHOMA |
1 |
0.0001 |
| 220 |
EJECTION FRACTION DECREASED |
1 |
0.0001 |
| 221 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 222 |
COMA |
3 |
0.0001 |
| 223 |
ABSCESS |
1 |
0.0001 |
| 224 |
GENERALISED TONIC-CLONIC SEIZURE |
1 |
0.0001 |
| 225 |
DRUG LEVEL INCREASED |
1 |
0.0001 |
| 226 |
VISUAL ACUITY REDUCED |
2 |
0.0001 |
| 227 |
GAIT INABILITY |
2 |
0.0001 |
| 228 |
SCAR |
1 |
0.0001 |
| 229 |
NEUROTOXICITY |
1 |
0.0001 |
| 230 |
PANCREATITIS |
3 |
0.0001 |
| 231 |
ASPARTATE AMINOTRANSFERASE INCREASED |
3 |
0.0001 |
| 232 |
SYNOVITIS |
1 |
0.0001 |
| 233 |
END STAGE RENAL DISEASE |
1 |
0.0001 |
| 234 |
EYE PAIN |
3 |
0.0001 |
| 235 |
PHOTOPHOBIA |
1 |
0.0001 |
| 236 |
DEHYDRATION |
7 |
0.0001 |
| 237 |
PULMONARY FIBROSIS |
1 |
0.0001 |
| 238 |
ACUTE RESPIRATORY FAILURE |
1 |
0.0001 |
| 239 |
DISORIENTATION |
2 |
0.0001 |
| 240 |
MELAENA |
1 |
0.0000 |
| 241 |
DRUG INTERACTION |
7 |
0.0000 |
| 242 |
PRODUCT USE ISSUE |
8 |
0.0000 |
| 243 |
PRODUCT PRESCRIBING ERROR |
1 |
0.0000 |
| 244 |
DIABETIC KETOACIDOSIS |
1 |
0.0000 |
| 245 |
INFECTION |
6 |
0.0000 |
| 246 |
HYPOGLYCAEMIA |
2 |
0.0000 |
| 247 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 248 |
LEUKOPENIA |
2 |
0.0000 |
| 249 |
HYPOPHAGIA |
1 |
0.0000 |
| 250 |
HEPATITIS |
1 |
0.0000 |
| 251 |
SKIN ULCER |
1 |
0.0000 |
| 252 |
RESPIRATORY TRACT INFECTION |
1 |
0.0000 |
| 253 |
ARTHRITIS |
3 |
0.0000 |
| 254 |
BRADYCARDIA |
2 |
0.0000 |
| 255 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 256 |
MENTAL STATUS CHANGES |
1 |
0.0000 |
| 257 |
HAEMOPTYSIS |
1 |
0.0000 |
| 258 |
PANCREATIC CARCINOMA |
1 |
0.0000 |
| 259 |
BLOOD POTASSIUM DECREASED |
1 |
0.0000 |
| 260 |
HEPATIC FAILURE |
1 |
0.0000 |
| 261 |
LACRIMATION INCREASED |
1 |
0.0000 |
| 262 |
NERVOUS SYSTEM DISORDER |
1 |
0.0000 |
| 263 |
PYREXIA |
11 |
0.0000 |
| 264 |
HEAD INJURY |
1 |
0.0000 |
| 265 |
NIGHT SWEATS |
1 |
0.0000 |
| 266 |
STAPHYLOCOCCAL INFECTION |
1 |
0.0000 |
| 267 |
SKIN DISORDER |
1 |
0.0000 |
| 268 |
HAEMATURIA |
1 |
0.0000 |
| 269 |
DELIRIUM |
1 |
0.0000 |
| 270 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 271 |
C-REACTIVE PROTEIN INCREASED |
1 |
0.0000 |
| 272 |
HEPATIC FUNCTION ABNORMAL |
1 |
0.0000 |
| 273 |
EPISTAXIS |
2 |
0.0000 |
| 274 |
INTESTINAL OBSTRUCTION |
1 |
0.0000 |
| 275 |
ABDOMINAL DISCOMFORT |
4 |
0.0000 |
| 276 |
MENTAL DISORDER |
1 |
0.0000 |
| 277 |
THERAPEUTIC RESPONSE UNEXPECTED |
1 |
0.0000 |
| 278 |
NEPHROLITHIASIS |
1 |
0.0000 |
| 279 |
SKIN DISCOLOURATION |
1 |
0.0000 |
| 280 |
DIARRHOEA |
14 |
0.0000 |
| 281 |
ASTHENIA |
8 |
0.0000 |
| 282 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
1 |
0.0000 |
| 283 |
MALAISE |
9 |
0.0000 |
| 284 |
CELLULITIS |
1 |
0.0000 |
| 285 |
INFLAMMATION |
1 |
0.0000 |
| 286 |
MUSCULOSKELETAL PAIN |
1 |
0.0000 |
| 287 |
OEDEMA |
1 |
0.0000 |
| 288 |
ANAPHYLACTIC REACTION |
1 |
0.0000 |
| 289 |
WEIGHT DECREASED |
5 |
0.0000 |
| 290 |
THROMBOCYTOPENIA |
2 |
0.0000 |
| 291 |
HYPONATRAEMIA |
1 |
0.0000 |
| 292 |
DYSPHONIA |
1 |
0.0000 |
| 293 |
JOINT SWELLING |
2 |
0.0000 |
| 294 |
THERAPEUTIC RESPONSE DECREASED |
1 |
0.0000 |
| 295 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 296 |
RHINORRHOEA |
1 |
0.0000 |
| 297 |
AMNESIA |
1 |
0.0000 |
| 298 |
FEBRILE NEUTROPENIA |
1 |
0.0000 |
| 299 |
ABDOMINAL PAIN UPPER |
3 |
0.0000 |
| 300 |
BURNING SENSATION |
1 |
0.0000 |
| 301 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 302 |
CARDIAC FAILURE |
1 |
0.0000 |
| 303 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 304 |
DYSPNOEA |
6 |
0.0000 |
| 305 |
ANAEMIA |
2 |
0.0000 |
| 306 |
GAIT DISTURBANCE |
2 |
0.0000 |
| 307 |
SOMNOLENCE |
2 |
0.0000 |
| 308 |
SINUSITIS |
1 |
0.0000 |
| 309 |
ILLNESS |
1 |
0.0000 |
| 310 |
HAEMORRHAGE |
1 |
0.0000 |
| 311 |
PNEUMONIA |
3 |
0.0000 |
| 312 |
SEPSIS |
1 |
0.0000 |
| 313 |
GENERAL PHYSICAL HEALTH DETERIORATION |
1 |
0.0000 |
| 314 |
ABDOMINAL PAIN |
2 |
0.0000 |
| 315 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 316 |
OEDEMA PERIPHERAL |
1 |
0.0000 |
| 317 |
PAIN |
5 |
0.0000 |
| 318 |
DIZZINESS |
4 |
0.0000 |
| 319 |
PRODUCT QUALITY ISSUE |
1 |
0.0000 |
| 320 |
MEMORY IMPAIRMENT |
1 |
0.0000 |
| 321 |
ARTHRALGIA |
3 |
0.0000 |
| 322 |
COUGH |
2 |
0.0000 |
| 323 |
HYPOAESTHESIA |
1 |
0.0000 |
| 324 |
TREMOR |
1 |
0.0000 |
| 325 |
FALL |
2 |
0.0000 |
| 326 |
MYALGIA |
1 |
0.0000 |
| 327 |
URINARY TRACT INFECTION |
1 |
0.0000 |
| 328 |
DEATH |
5 |
0.0000 |
| 329 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 330 |
PRURITUS |
2 |
0.0000 |
| 331 |
HYPOTENSION |
1 |
0.0000 |
| 332 |
ERYTHEMA |
1 |
0.0000 |
| 333 |
HYPERTENSION |
1 |
0.0000 |
| 334 |
OVERDOSE |
1 |
0.0000 |
| 335 |
RASH |
2 |
0.0000 |
| 336 |
WEIGHT INCREASED |
1 |
0.0000 |
| 337 |
DEPRESSION |
1 |
0.0000 |
| 338 |
INCORRECT DOSE ADMINISTERED |
1 |
0.0000 |
| 339 |
BACK PAIN |
1 |
0.0000 |
| 340 |
FATIGUE |
3 |
0.0000 |
| 341 |
INSOMNIA |
1 |
0.0000 |
| 342 |
HEADACHE |
2 |
0.0000 |